Skip links
Companies
› Belgium › Pharmalex Belgium
Pharmalex Belgium logo

Pharmalex Belgium

Public Limited Company Active

Registration No.
0667829063
Incorporation Date
2016-12-19
Company Type
Public Limited Company
Address
Belgium
Website
www.pharmalex.be/
Source: Crossroads Bank for Enterprises (KBO/BCE)

Pharmalex Belgium is a Public Limited Company registered in Belgium under 0667829063, and its current status with Crossroads Bank for Enterprises (KBO/BCE) is active. The company was incorporated on 19 December 2016 and lists its registered address as Belgium. 1 shareholder is on record for Pharmalex Belgium, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last updated on 19 October 2026.

Data Provenance
This record is sourced directly from official government registries, including Crossroads Bank for Enterprises (KBO/BCE).

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

1

One shareholder is currently on record for Pharmalex Belgium, reflecting the registre des actions nominatives (register of registered shares) kept by the company under the Code des sociétés et des associations rather than a public filing.

The largest of these is AmerisourceBergen International B.V, holding 100% — a majority holding.

Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
AmerisourceBergen International B.V 100% Crossroads Bank for Enterprises (KBO/BCE)

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

No current officer appointment is recorded for Pharmalex Belgium in this view — all 5 records shown are former appointments, filed with Crossroads Bank for Enterprises (KBO/BCE).

The register reports 13 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at Pharmalex Belgium sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

FD
Francois De Witte RESIGNED

Appointed
2023-01-24
Resigned
2028-02-08
Residence
🇧🇪 Belgium
Occupation
Director

LC
Laurent Couston RESIGNED

Appointed
2023-06-30
Resigned
2028-02-08
Residence
🇧🇪 Belgium
Occupation
Director

CG
Christopher Gauglitz RESIGNED

Appointed
2024-11-01
Resigned
2030-11-01
Residence
🇧🇪 Belgium
Occupation
Director

PF
Pharmalex France Sas RESIGNED

Appointed
2024-11-01
Resigned
2030-11-01
Residence
🇧🇪 Belgium
Occupation
Director

AP
Anne Peeters RESIGNED

Appointed
2024-11-01
Resigned
2030-11-01
Residence
🇧🇪 Belgium
Occupation
Director

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

Pharmalex Belgium sits 3 levels below its ultimate parent, Cencora, Inc., registered in United States. The full chain up to Cencora, Inc. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Pharmalex Belgium's own shareholder record.

Ultimate HQ
Cencora, Inc.
United States

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on Pharmalex Belgium?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns Pharmalex Belgium?

One shareholder is currently on record for Pharmalex Belgium, reflecting the registre des actions nominatives (register of registered shares) kept by the company under the Code des sociétés et des associations rather than a public filing. The largest of these is AmerisourceBergen International B.V, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is Pharmalex Belgium's UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for Pharmalex Belgium is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does Pharmalex Belgium have on record?

1 shareholder is shown on record for Pharmalex Belgium.

What is Pharmalex Belgium's company registration number?

Pharmalex Belgium's registration number is 0667829063, filed with Crossroads Bank for Enterprises (KBO/BCE) in Belgium. Its current status on the register is active.

Is Pharmalex Belgium still an active company?

Pharmalex Belgium's status on Crossroads Bank for Enterprises (KBO/BCE) is listed as active.

When was Pharmalex Belgium incorporated?

Pharmalex Belgium was incorporated on 19 December 2016, according to Crossroads Bank for Enterprises (KBO/BCE).

What is Pharmalex Belgium's registered address?

The registered address on file for Pharmalex Belgium is Belgium.

What legal structure is Pharmalex Belgium registered as?

Pharmalex Belgium is registered as a Public Limited Company in Belgium.

Who are the officers/directors of Pharmalex Belgium?

No current officer appointment is recorded for Pharmalex Belgium in this view — all 5 records shown are former appointments, filed with Crossroads Bank for Enterprises (KBO/BCE). Management authority at Pharmalex Belgium sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does Pharmalex Belgium have a parent company or subsidiaries?

Pharmalex Belgium sits 3 levels below its ultimate parent, Cencora, Inc., registered in United States.

Can Zavia monitor changes to Pharmalex Belgium's ownership over time?

This profile reflects a point-in-time snapshot from Crossroads Bank for Enterprises (KBO/BCE). Zavia's monitoring API can track changes to Pharmalex Belgium's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access Pharmalex Belgium's data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Belgium, so records like Pharmalex Belgium's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last synced on 19 October 2026.

This website uses cookies to improve your web experience.